Heart Disease News and Research

Latest Heart Disease News and Research

STOP Obesity Alliance: Adults lack information about effective weight loss methods and strategies

Primary care physicians agree they have a role in addressing obesity, but say they do not have the right weight management resources. Obese or heavier adults take responsibility for weight loss, but adults who need to lose weight may lack information about effective weight loss methods and strategies. These findings and others come from new research commissioned and released today by the Strategies to Overcome and Prevent Obesity Alliance.

19 Mar 2010

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.

19 Mar 2010

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

A $10.2 million commitment from the Robertson Foundation to create a state-of-the-art Translational Cell Therapy Center (TCTC) will advance Duke Medicine's pioneering cell therapy research and treatment programs for children and adults with cancer, cerebral palsy, stroke and brain injuries suffered at birth.

19 Mar 2010

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

Pharmaceutical Research and Manufacturers of America President and CEO Billy Tauzin today honored Ron and Raychel Bartek for their dedicated work driving awareness of Friedreich's ataxia, a debilitating, life-threatening, rare disease.

19 Mar 2010

FDA approves expanded indication for Boston Scientific's CRT-Ds

Boston Scientific Corporation today announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. The panel recommended the expansion include the majority of the studied population of the landmark MADIT-CRT clinical trial, which evaluated the ability of these devices to slow the progression of heart failure in patients with asymptomatic or mild heart failure.

19 Mar 2010

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

Almost two-thirds (62%) of Canadians age 65 and older living in the community in six provinces are using five or more classes of prescription drugs, according to a study released today by the Canadian Institute for Health Information.

19 Mar 2010

NAMI launches new health education program for people with serious mental illness

The National Alliance on Mental Illness has launched a new health education program to promote sound "mind and body" health practices among individuals who live with serious mental illness.

19 Mar 2010

Mars supports new national school nutrition standard

Mars, Incorporated today announced its support for improved school food nutrition standards so that more nutritious products are available to students nationwide. A key component of a comprehensive health and wellness campaign, the announcement was made in partnership with other industry leaders and public health organizations.

19 Mar 2010

Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD

Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices may play in weight reduction for obese patients with chronic end-stage heart failure who are considered for heart transplantation.

19 Mar 2010

Atritech to initiate confirmatory study of WATCHMAN LAA Closure Device

Atritech, Inc., an emerging medical device company, announced today that it has obtained clarity from the U.S. Food and Drug Agency on the regulatory path towards full approval of its WATCHMAN® Left Atrial Appendage Closure Technology in the United States.

19 Mar 2010

CHC: Passage of President Obama's health care reform proposal would improve quality of life for Latinos

The Congressional Hispanic Caucus today called for passage of President Obama's health care reform proposal, saying that it would greatly improve the quality of life for millions of Latinos. The measure is expected to expand coverage to 8.8 million Latinos, or 60% of the currently uninsured Hispanic community.

19 Mar 2010

Kaiser Permanente study: Snapshot of the prevalence of extreme obesity in younger children

Extreme obesity is affecting more children at younger ages, with 12 percent of black teenage girls, 11.2 percent of Hispanic teenage boys, 7.3 percent of boys and 5.5 percent of girls now classified as extremely obese, according to a Kaiser Permanente study of 710,949 children and teens that appears online in the Journal of Pediatrics.

19 Mar 2010

Coercing Congress members to vote for healthcare plan: Physicians' file lawsuit

On Thursday, March 18, lawyers from the U.S. Department of Justice will appear in Federal District Court for oral argument in opposition to a request by physicians opposed to President Barack Obama's healthcare bill for an injunction barring his Administration "from undertaking in the future to intimidate or coerce any member of Congress" to vote for the plan.

19 Mar 2010

Cedars-Sinai Medical Center announces clinical trial of minimally invasive procedure for opening carotid arteries

Patients who suffer from plaque-related narrowing of a carotid artery but are not good candidates for open surgery may be eligible to participate in a clinical trial at Cedars-Sinai Medical Center of a minimally invasive procedure designed to open carotid arteries the way angioplasty and stenting clear arteries of the heart.

19 Mar 2010

Phase 1B clinical study initiated to evaluate safety and efficacy of PMX-60056

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B clinical study to evaluate the safety and efficacy of PMX-60056 in reversing the anticoagulant activity of low molecule weight heparin (LMWH).

19 Mar 2010

Cameron Health initiates clinical trial of minimally invasive S-ICD System for patients at risk of SCA

Cameron Health, Inc. today announced the commencement of the company's pivotal clinical trial to gain U.S. approval of its Subcutaneous Implantable Defibrillator (S-ICD®) System. The minimally invasive S-ICD System is prescribed for use in patients at risk of Sudden Cardiac Arrest (SCA). The S-ICD System is unique in that the implantation of the system is entirely subcutaneous; no leads are in or on the heart.

19 Mar 2010

Wellpoint draws flak for infulfilled promise to help uninsured

The health insurance company WellPoint delivered on only about one-fifth of a $30-million pledge to help the uninsured, the Los Angeles Times reports.

19 Mar 2010

Stiff skin syndrome cause found

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about scleroderma, a condition affecting about one in 5,000 people that leads to hardening of the skin as well as other debilitating and often life-threatening problems. The findings, which appear this week in Science Translational Medicine, open doors to testing new treatments.

18 Mar 2010

Mrs. Obama on childhood obesity

Last month First Lady Michelle Obama launched a programme called “Let’s Move” aiming at reducing and eradicating the childhood obesity epidemic in the existing generation so that the nation as a whole attains a healthy adulthood in the coming decades.

18 Mar 2010

U.S.-based CRO licenses NewCardio's QTinno software solution for automating cardiac safety analysis

NewCardio, Inc., a cardiac diagnostic technology provider, announced today that a U.S.-based CRO that provides early phase and specialty clinical drug development services to the pharmaceutical industry, has signed an MSA, licensing NewCardio's QTinno™ software solution in order to deliver fully automated cardiac safety analysis in early phase QT studies.

18 Mar 2010

Heart Disease News and Research

Latest Heart Disease News and Research

STOP Obesity Alliance: Adults lack information about effective weight loss methods and strategies

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Robertson Foundation commits $10.2M for Duke Medicine's cell therapy research

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

FDA approves expanded indication for Boston Scientific's CRT-Ds

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

NAMI launches new health education program for people with serious mental illness

Mars supports new national school nutrition standard

Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD

Atritech to initiate confirmatory study of WATCHMAN LAA Closure Device

CHC: Passage of President Obama's health care reform proposal would improve quality of life for Latinos

Kaiser Permanente study: Snapshot of the prevalence of extreme obesity in younger children

Coercing Congress members to vote for healthcare plan: Physicians' file lawsuit

Cedars-Sinai Medical Center announces clinical trial of minimally invasive procedure for opening carotid arteries

Phase 1B clinical study initiated to evaluate safety and efficacy of PMX-60056

Cameron Health initiates clinical trial of minimally invasive S-ICD System for patients at risk of SCA

Wellpoint draws flak for infulfilled promise to help uninsured

Stiff skin syndrome cause found

Mrs. Obama on childhood obesity

U.S.-based CRO licenses NewCardio's QTinno software solution for automating cardiac safety analysis

Innovation in neuroscience drug discovery - eBook eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Heart Disease News and Research

Latest Heart Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in